vs
Astrana Health, Inc.（ASTH）とTyler Technologies（TYL）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $575.2M、Tyler Technologiesの約1.7倍）。Tyler Technologiesの純利益率が高く（11.4% vs 0.7%、差は10.7%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 6.3%）。Tyler Technologiesの直近四半期フリーキャッシュフローが多い（$239.6M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 6.0%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
Tyler Technologies, Inc.はアメリカ合衆国テキサス州プラーノに本社を置くテクノロジー企業で、米国公共部門向けに独自開発の専用ソフトウェアを提供している。現在米国内17州とカナダ・オンタリオ州トロントにオフィスを展開している。
ASTH vs TYL — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $575.2M |
| 純利益 | $6.6M | $65.5M |
| 粗利率 | — | 45.5% |
| 営業利益率 | 1.9% | 13.0% |
| 純利益率 | 0.7% | 11.4% |
| 売上前年比 | 42.9% | 6.3% |
| 純利益前年比 | 184.4% | 0.5% |
| EPS（希薄化後） | $0.12 | $1.50 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $575.2M | ||
| Q3 25 | $956.0M | $595.9M | ||
| Q2 25 | $654.8M | $596.1M | ||
| Q1 25 | $620.4M | $565.2M | ||
| Q4 24 | $665.2M | $541.1M | ||
| Q3 24 | $478.7M | $543.3M | ||
| Q2 24 | $486.3M | $541.0M | ||
| Q1 24 | $404.4M | $512.4M |
| Q4 25 | $6.6M | $65.5M | ||
| Q3 25 | $373.0K | $84.4M | ||
| Q2 25 | $9.4M | $84.6M | ||
| Q1 25 | $6.7M | $81.1M | ||
| Q4 24 | $-7.8M | $65.2M | ||
| Q3 24 | $16.1M | $75.9M | ||
| Q2 24 | $19.2M | $67.7M | ||
| Q1 24 | $14.8M | $54.2M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 47.2% | ||
| Q2 25 | — | 45.8% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 43.8% | ||
| Q3 24 | — | 43.7% | ||
| Q2 24 | — | 44.0% | ||
| Q1 24 | — | 43.7% |
| Q4 25 | 1.9% | 13.0% | ||
| Q3 25 | 2.0% | 16.4% | ||
| Q2 25 | 3.1% | 16.0% | ||
| Q1 25 | 3.3% | 15.8% | ||
| Q4 24 | 0.1% | 13.2% | ||
| Q3 24 | 5.9% | 15.2% | ||
| Q2 24 | 6.2% | 14.4% | ||
| Q1 24 | 7.5% | 13.1% |
| Q4 25 | 0.7% | 11.4% | ||
| Q3 25 | 0.0% | 14.2% | ||
| Q2 25 | 1.4% | 14.2% | ||
| Q1 25 | 1.1% | 14.3% | ||
| Q4 24 | -1.2% | 12.1% | ||
| Q3 24 | 3.4% | 14.0% | ||
| Q2 24 | 3.9% | 12.5% | ||
| Q1 24 | 3.7% | 10.6% |
| Q4 25 | $0.12 | $1.50 | ||
| Q3 25 | $0.01 | $1.93 | ||
| Q2 25 | $0.19 | $1.93 | ||
| Q1 25 | $0.14 | $1.84 | ||
| Q4 24 | $-0.14 | $1.48 | ||
| Q3 24 | $0.33 | $1.74 | ||
| Q2 24 | $0.40 | $1.57 | ||
| Q1 24 | $0.31 | $1.26 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $1.1B |
| 総負債低いほど良い | — | $599.7M |
| 株主資本純資産 | $779.3M | $3.7B |
| 総資産 | $2.2B | $5.6B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.16× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $1.1B | ||
| Q3 25 | $463.4M | $950.8M | ||
| Q2 25 | $342.1M | $892.3M | ||
| Q1 25 | $260.9M | $807.4M | ||
| Q4 24 | $290.8M | $768.0M | ||
| Q3 24 | $350.3M | $544.3M | ||
| Q2 24 | $327.7M | $258.0M | ||
| Q1 24 | $337.3M | $196.9M |
| Q4 25 | — | $599.7M | ||
| Q3 25 | — | $599.2M | ||
| Q2 25 | — | $598.8M | ||
| Q1 25 | — | $598.4M | ||
| Q4 24 | — | $597.9M | ||
| Q3 24 | — | $597.5M | ||
| Q2 24 | — | $597.1M | ||
| Q1 24 | — | $596.6M |
| Q4 25 | $779.3M | $3.7B | ||
| Q3 25 | $775.5M | $3.6B | ||
| Q2 25 | $765.5M | $3.6B | ||
| Q1 25 | $745.4M | $3.5B | ||
| Q4 24 | $712.7M | $3.4B | ||
| Q3 24 | $704.6M | $3.3B | ||
| Q2 24 | $678.9M | $3.1B | ||
| Q1 24 | $653.5M | $3.0B |
| Q4 25 | $2.2B | $5.6B | ||
| Q3 25 | $2.2B | $5.5B | ||
| Q2 25 | $1.4B | $5.4B | ||
| Q1 25 | $1.3B | $5.2B | ||
| Q4 24 | $1.4B | $5.2B | ||
| Q3 24 | $1.3B | $5.0B | ||
| Q2 24 | $1.3B | $4.8B | ||
| Q1 24 | $1.2B | $4.6B |
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.17× | ||
| Q2 25 | — | 0.16× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.19× | ||
| Q1 24 | — | 0.20× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $243.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $239.6M |
| FCFマージンFCF / 売上 | -0.6% | 41.7% |
| 設備投資強度設備投資 / 売上 | 0.3% | 0.8% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 3.72× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $637.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $243.9M | ||
| Q3 25 | $10.0M | $255.2M | ||
| Q2 25 | $90.9M | $98.3M | ||
| Q1 25 | $16.6M | $56.2M | ||
| Q4 24 | $-10.9M | $224.8M | ||
| Q3 24 | $34.0M | $263.7M | ||
| Q2 24 | $23.2M | $64.3M | ||
| Q1 24 | $6.0M | $71.8M |
| Q4 25 | $-6.0M | $239.6M | ||
| Q3 25 | $7.4M | $251.3M | ||
| Q2 25 | $89.5M | $92.8M | ||
| Q1 25 | $13.6M | $53.8M | ||
| Q4 24 | $-13.5M | $221.0M | ||
| Q3 24 | $31.7M | $260.8M | ||
| Q2 24 | $20.4M | $57.7M | ||
| Q1 24 | $5.6M | $64.6M |
| Q4 25 | -0.6% | 41.7% | ||
| Q3 25 | 0.8% | 42.2% | ||
| Q2 25 | 13.7% | 15.6% | ||
| Q1 25 | 2.2% | 9.5% | ||
| Q4 24 | -2.0% | 40.8% | ||
| Q3 24 | 6.6% | 48.0% | ||
| Q2 24 | 4.2% | 10.7% | ||
| Q1 24 | 1.4% | 12.6% |
| Q4 25 | 0.3% | 0.8% | ||
| Q3 25 | 0.3% | 0.7% | ||
| Q2 25 | 0.2% | 0.9% | ||
| Q1 25 | 0.5% | 0.4% | ||
| Q4 24 | 0.4% | 0.7% | ||
| Q3 24 | 0.5% | 0.5% | ||
| Q2 24 | 0.6% | 1.2% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | -0.44× | 3.72× | ||
| Q3 25 | 26.69× | 3.02× | ||
| Q2 25 | 9.65× | 1.16× | ||
| Q1 25 | 2.48× | 0.69× | ||
| Q4 24 | — | 3.45× | ||
| Q3 24 | 2.11× | 3.47× | ||
| Q2 24 | 1.21× | 0.95× | ||
| Q1 24 | 0.40× | 1.33× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
TYL
| Saas Arrangements | $186.1M | 32% |
| Platform Technologies Segment | $143.3M | 25% |
| Maintenance | $109.4M | 19% |
| Professional Services | $55.3M | 10% |
| Nonrecurring Revenue | $51.3M | 9% |
| Other | $21.4M | 4% |
| Hardware And Other | $8.4M | 1% |
